Literature DB >> 33296145

Mechanisms of small cell lung cancer metastasis.

Julie Ko1,2, Monte M Winslow2,3, Julien Sage1,2.   

Abstract

Metastasis is a major cause of morbidity and mortality in cancer patients. However, the molecular and cellular mechanisms underlying the ability of cancer cells to metastasize remain relatively poorly understood. Among all solid tumors, small cell lung cancer (SCLC) has remarkable metastatic proclivity, with a majority of patients diagnosed with metastatic disease. Our understanding of SCLC metastasis has been hampered for many years by the paucity of material from primary tumors and metastases, as well as the lack of faithful pre-clinical models. Here, we review recent advances that are helping circumvent these limitations. These advances include methods that employ circulating tumor cells from the blood of SCLC patients and the development of diverse genetically engineered mouse models of metastatic SCLC. New insights into the cellular mechanisms of SCLC metastasis include observations of cell fate changes associated with increased metastatic ability. Ongoing studies on cell migration and organ tropism promise to expand our understanding of SCLC metastasis. Ultimately, a better molecular understanding of metastatic phenotypes may be translated into new therapeutic options to limit metastatic spread and treat metastatic SCLC.
© 2020 The Authors. Published under the terms of the CC BY 4.0 license.

Entities:  

Keywords:  NFIB; SCLC; lung cancer; metastasis; tumor heterogeneity

Mesh:

Year:  2020        PMID: 33296145      PMCID: PMC7799359          DOI: 10.15252/emmm.202013122

Source DB:  PubMed          Journal:  EMBO Mol Med        ISSN: 1757-4676            Impact factor:   14.260


  121 in total

1.  Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group.

Authors:  A Aupérin; R Arriagada; J P Pignon; C Le Péchoux; A Gregor; R J Stephens; P E Kristjansen; B E Johnson; H Ueoka; H Wagner; J Aisner
Journal:  N Engl J Med       Date:  1999-08-12       Impact factor: 91.245

2.  Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies.

Authors:  Hyun Cheol Chung; Sarina A Piha-Paul; Jose Lopez-Martin; Jan H M Schellens; Steven Kao; Wilson H Miller; Jean-Pierre Delord; Bo Gao; David Planchard; Maya Gottfried; Alona Zer; Shadia I Jalal; Nicolas Penel; Janice M Mehnert; Ignacio Matos; Jaafar Bennouna; Dong-Wan Kim; Lei Xu; Suba Krishnan; Kevin Norwood; Patrick A Ott
Journal:  J Thorac Oncol       Date:  2019-12-20       Impact factor: 15.609

Review 3.  Surgery for limited-stage small-cell lung cancer.

Authors:  Hayley Barnes; Katharine See; Stephen Barnett; Renée Manser
Journal:  Cochrane Database Syst Rev       Date:  2017-04-21

4.  Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer.

Authors:  Louise Carter; Dominic G Rothwell; Barbara Mesquita; Christopher Smowton; Hui Sun Leong; Fabiola Fernandez-Gutierrez; Yaoyong Li; Deborah J Burt; Jenny Antonello; Christopher J Morrow; Cassandra L Hodgkinson; Karen Morris; Lynsey Priest; Mathew Carter; Crispin Miller; Andrew Hughes; Fiona Blackhall; Caroline Dive; Ged Brady
Journal:  Nat Med       Date:  2016-11-21       Impact factor: 53.440

5.  Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma.

Authors:  Bethany E Schaffer; Kwon-Sik Park; Gloria Yiu; Jamie F Conklin; Chenwei Lin; Deborah L Burkhart; Anthony N Karnezis; E Alejandro Sweet-Cordero; Julien Sage
Journal:  Cancer Res       Date:  2010-04-20       Impact factor: 12.701

6.  Downregulation of CXCR4 by SDF-KDEL in SBC-5 cells inhibits their migration in vitro and organ metastasis in vivo.

Authors:  Ningqiang Ma; Hailin Pang; Weiwei Shen; Feng Zhang; Zaoxun Cui; Junyan Wang; Jianlin Wang; Lili Liu; Helong Zhang
Journal:  Int J Mol Med       Date:  2014-12-10       Impact factor: 4.101

7.  High expression of integrin beta1 and p53 is a greater poor prognostic factor than clinical stage in small-cell lung cancer.

Authors:  Fumihiro Oshita; Yoichi Kameda; Nobuyuki Hamanaka; Haruhiro Saito; Kouzo Yamada; Kazumasa Noda; Aki Mitsuda
Journal:  Am J Clin Oncol       Date:  2004-06       Impact factor: 2.339

Review 8.  Pleural effusion in lung cancer: more questions than answers.

Authors:  Marios E Froudarakis
Journal:  Respiration       Date:  2012-05-07       Impact factor: 3.580

9.  Molecular Characterization of Circulating Tumor Cells Enriched by A Microfluidic Platform in Patients with Small-Cell Lung Cancer.

Authors:  Eva Obermayr; Christiane Agreiter; Eva Schuster; Hannah Fabikan; Christoph Weinlinger; Katarina Baluchova; Gerhard Hamilton; Maximilian Hochmair; Robert Zeillinger
Journal:  Cells       Date:  2019-08-13       Impact factor: 6.600

10.  Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition.

Authors:  Deshui Jia; Arnaud Augert; Dong-Wook Kim; Emily Eastwood; Nan Wu; Ali H Ibrahim; Kee-Beom Kim; Colin T Dunn; Smitha P S Pillai; Adi F Gazdar; Hamid Bolouri; Kwon-Sik Park; David MacPherson
Journal:  Cancer Discov       Date:  2018-09-04       Impact factor: 38.272

View more
  17 in total

1.  Histone deacetylase 6-mediated downregulation of TMEM100 expedites the development and progression of non-small cell lung cancer.

Authors:  Yanyun Wang; Minwen Ha; Man Li; Lin Zhang; Yitong Chen
Journal:  Hum Cell       Date:  2021-10-23       Impact factor: 4.174

2.  Myc manipulates the miRNA content and biologic functions of small cell lung cancer cell-derived small extracellular vesicles.

Authors:  Onur Tokgün; Kubilay İnci
Journal:  Mol Biol Rep       Date:  2022-06-12       Impact factor: 2.742

3.  Cellular and Molecular Profiling of Tumor Microenvironment and Early-Stage Lung Cancer.

Authors:  Radu Pirlog; Paul Chiroi; Ioana Rusu; Ancuta Maria Jurj; Liviuta Budisan; Cecilia Pop-Bica; Cornelia Braicu; Doinita Crisan; Jean-Christophe Sabourin; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

4.  Unusual presentation of a small cell lung cancer with bilateral breast metastases: Case report and a brief review of the literature.

Authors:  Mark Bannon; Creticus Marak; Adrita Ashraf; Chelsea Smith; Matthew Nunley; Achuta Kumar Guddati; Prashant Kaushik
Journal:  Respir Med Case Rep       Date:  2022-06-27

5.  Integrated 5-hydroxymethylcytosine and fragmentation signatures as enhanced biomarkers in lung cancer.

Authors:  Xinlei Hu; Kai Luo; Hui Shi; Xiaoqin Yan; Ruichen Huang; Bi Zhao; Jun Zhang; Dan Xie; Wei Zhang
Journal:  Clin Epigenetics       Date:  2022-01-24       Impact factor: 6.551

6.  Clinical characteristics and prognostic model for extensive-stage small cell lung cancer: A retrospective study over an 8-year period.

Authors:  Jun Ni; Xiaotong Zhang; Hanping Wang; Xiaoyan Si; Yan Xu; Jing Zhao; Minjiang Chen; Li Zhang; Mengzhao Wang
Journal:  Thorac Cancer       Date:  2021-12-30       Impact factor: 3.223

7.  De novo deoxyribonucleotide biosynthesis regulates cell growth and tumor progression in small-cell lung carcinoma.

Authors:  Ami Maruyama; Yuzo Sato; Joji Nakayama; Junko Murai; Takamasa Ishikawa; Tomoyoshi Soga; Hideki Makinoshima
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

8.  Rlf-Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer.

Authors:  Triantafyllia Karakousi; Allison L Richards; Metamia Ciampricotti; Àlvaro Quintanal-Villalonga; Angeliki Karatza; Rebecca Caeser; Emily A Costa; Viola Allaj; Parvathy Manoj; Kyle B Spainhower; Faruk E Kombak; Francisco J Sanchez-Rivera; Janneke E Jaspers; Anastasia-Maria Zavitsanou; Danilo Maddalo; Andrea Ventura; William M Rideout; Elliot H Akama-Garren; Tyler Jacks; Mark T A Donoghue; Triparna Sen; Trudy G Oliver; John T Poirier; Thales Papagiannakopoulos; Charles M Rudin
Journal:  Cancer Discov       Date:  2021-12-01       Impact factor: 38.272

Review 9.  Modeling metastasis in mice: a closer look.

Authors:  Arianna Giacobbe; Cory Abate-Shen
Journal:  Trends Cancer       Date:  2021-07-22

Review 10.  Progression and metastasis of small cell lung carcinoma: the role of the PI3K/Akt/mTOR pathway and metabolic alterations.

Authors:  Ildiko Krencz; Daniel Sztankovics; Titanilla Danko; Anna Sebestyen; Andras Khoor
Journal:  Cancer Metastasis Rev       Date:  2021-12-27       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.